PAKOLA STEVE (Chief Medical Officer) sold 20.9% of their position (56.33K shares) of REGENXBIO INC. on the open market
Open‑market sale worth $688.8K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 7/2/2026ACC: 0001700659-26-000012
Officer· Chief Medical Officer
Since Apr 2019
-56.33K
Net shares
Net seller
$688.8K
Total sold
2
Open market trades
0B · 2S
4
Total transactions
36.73K acquired · 93.06K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−19.61K
Price / share
$11.04
Trade value
$216.47K
% of position
8.4%
6/29/2026
232.62K→213.01K
Common Stock
Direct
Shares
+36.73K
Price / share
$7.86
Trade value
$288.66K
% of position
17.2%
7/1/2026
213.01K→249.73K
Common Stock
Direct
Shares
−36.73K
Price / share
$12.86
Trade value
$472.28K
% of position
14.7%
7/1/2026
249.73K→213.01K
Total
Net shares
−19.61K
Net value
-$400.10K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/29/2026 | S · Sale | −19.61K | $11.04 | $216.47K | 8.4% | 232.62K | 213.01K |
| Common Stock Direct | 7/1/2026 | M · Option Exercise | +36.73K | $7.86 | $288.66K | 17.2% | 213.01K | 249.73K |
| Common Stock Direct | 7/1/2026 | S · Sale | −36.73K | $12.86 | $472.28K | 14.7% | 249.73K | 213.01K |
| Total | −19.61K | -$400.10K | ||||||
Derivative Transactions1
Stock Options (Right to Buy)
Direct
Converts to
Common Stock
36.73K shares
Shares
−36.73K
Strike price
7.86
Held after
66.97K
Exercisable
—
7/1/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy) Direct | Common Stock36.73K shares | 7/1/2026 | M · Option Exercise | −36.73K | 7.86 | — | 66.97K |